Event Date |
11/09/2006 to 11/09/2006 |
Event Location |
Washington DC |
Event Facility |
The Ritz-Carlton, Washington, DC
1150 22nd Street NW
Washington, DC 20037 |
Agenda |
Registration and Dinner 6:00-6:45 pm
Welcome and Introduction 6:45-6:50
Formal Presentation 6:50-8:35
Summary 8:35-8:45 pm
|
Overview |
Advances in Opioid Analgesia: Maximizing Benefit While Minimizing Risk is part of a series of continuing medical education Dinner Dialogue that will discuss and weigh the risks and benefits of opioid therapy in the treatment of patients who present with chronic pain. Slides along with an algorithim, tools and faculty interaction will aid with the teaching of this important topic. |
Specialty |
Family Medicine
General Practitioner
Internal Medicine
Neurology
Pain Management
Primary Care
Rheumatology
RN - Neurology
RN - Pain
|
Intended Audience |
This activity has been designed to educate neurologists, family physicians, general practitioners, internal medicine specialists, rheumatologists, physical medicine and rehabilitation specialists, osteopathic medicine specialists, pharmacists and other physicians and healthcare professionals who treat patients with pain. |
Registration |
Enrollment for this course is complimentary. |
Sponsorship |
This educational activity is cosponsored by Thomson Professional Postgraduate Services®, Secaucus, NJ, and AHC Media LLC, and is conducted as a part of the National Initiative on Pain Control®, (NIPC®), sponsored by Thomson Professional Postgraduate Services®, Secaucus, NJ. |
Accreditation |
Thomson Professional Postgraduate Services® is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
|
AHC Media LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program, ACPE #381-999-06-030-L01, will be available October 26, 2006 to February 28, 2007. |
|
Credit Designation |
Thomson Professional Postgraduate Services® designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Statement of credit will be issued and mailed 6-8 weeks after the activity to those participants signing the registration list onsite.
|
Pharmacy Credit |
AHC Media LLC has designated 2.0 contact hours (0.20 CEUs) for this program. Participants will receive statements of credit six weeks after receipt of the completed evaluation form. Each attendee should claim only those contact hours that he/she actually spent in the activity. |
Faculty |
Seddon R. Savage, MS, MD
Associates Professor of Anesthesiology
Director, Dartmouth Center on Addiction
Recovery and Education
Dartmouth Medical School
Hanover, New Hampshire
|
Disclosure |
Seddon R. Savage, MS, MD has indicated that she is a member of the advisory board for Endo Pharmaceuticals. |
Grantor Support |
This CME/CE activity is supported by an unrestricted educational grant from Endo Pharmaceuticals Inc. |
Course Objectives |
- Determine those chronic pain patients most likely to benefit from opioid therapy, based on the potential risks and benefits
- Initiate a trial of opioid therapy and assess ongoing risks and benefits in the treatment of the chronic pain patient
- Optimize the analgesic potential of opioid therapy through titration, rotation, conversion and adjunctive therapy in the management of chronic pain
- Apply the basic documentation and medico-legal requirements necessary to support appropriate opioid prescribing
|
|
|
|
